AstraZeneca has announced that it is cutting about 1,600 jobs over three years, the Wall Street Journal reports. The Nature News blog adds that about 1,300 of those jobs are in research and development. The company will also be moving its headquarters from London to Cambridge in the UK.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.
Hong Kong is using DNA phenotyping to shame litterers.
A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.
NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.